<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Researchers will use plasma from patients recovering for at least 28Â days to increase antibody levels. The main findings from available data are as follows: (a)mortality may be reduced by plasma therapy in critically ill patients, (b) neutralizing antibody titers are increased and disappearance of SARS-CoV-2 RNA after CP therapy, and (c) beneficial effect on clinical symptoms after administration of convalescent plasma [
 <xref rid="bb0285" ref-type="bibr">57</xref>].
</p>
